José Lopes, PhD, managing science editor —

José holds a PhD in neuroscience from the University of Porto, Portugal. After postdocs at Weill Connell Medicine and Western University, where he studied the processes driving hypertension and Alzheimer’s disease, he moved on in 2016 to a career in science writing and communication. José is the author of several peer-reviewed papers and a book chapter and has presented his research in numerous international meetings.

Articles by José Lopes

Dutch Study Reveals New Genes and Disease Mechanisms Associated with ALS

Dutch researchers have identified new genes and biological mechanisms possibly involved in frontotemporal dementia (FTD) with and without amyotrophic lateral sclerosis (ALS). The study, “Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS,” appeared in the…

Israel’s BrainStorm Offers Encouraging Phase 2 Data on Stem-Cell Therapy NurOwn to Treat ALS

Israel’s BrainStorm Cell Therapeutics has announced positive top-line Phase 2 data on NurOwn, a customized stem-cell therapy technology to treat amyotrophic lateral sclerosis (ALS). BrainStorm has been developing and commercializing NurOwn in partnership with Ramot, the business engagement unit of Tel Aviv University. NurOwn enables the production of growth factors that…

Job Exposure to Extremely Low-Frequently Magnetic Fields Increases ALS Risk, Dutch Study Shows

Occupational exposure to extremely low-frequency magnetic fields (ELF-MFs) could trigger amyotrophic lateral sclerosis (ALS), a Dutch study shows. The study, “Occupational exposure and amyotrophic lateral sclerosis in a prospective cohort,” appeared in the journal Occupational & Environmental Medicine. Given that only 5 to 10 percent of ALS cases are hereditary, scientists…